Időskori makuladegeneráció: vizsgálatok itt: Németország
19 of 22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Where
- Bonn, Frankfurt am Main, Hamburg, Hanover, München, Münster, Tübingen
- Életkor
- 50 év and over
- People
- 960 worldwide
- Run by
- EyeBiotech Ltd.
See details and how to joinNCT07440225 - 2. fázisNot yet taking people in NémetországPhase 2 Study of ADX-038 in Participants With Geographic Atrophy
- Where
- Bonn, Giessen, Köln, Mainz, Muenster, Munich, Sulzbach, Tuebingen
- Életkor
- 60 év and over
- People
- 240 worldwide
- Run by
- ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00 - 2. fázisTaking peopleA Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- Where
- Bonn, Freiburg im Breisgau, Hanover, Heidelberg, Neubrandenburg, Tübingen, Ulm
- Életkor
- 55 év to 64 év
- People
- 110 worldwide
- Run by
- Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Bonn, Ludwigshafen Am Rhein, Munster, Tuebingen
- Életkor
- 50 év and over
- People
- 272 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00 - 3. fázisTaking peopleA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- Where
- Chemnitz, Duesseldorf, Goettingen, Hanover, Rostock, Wuerzburg
- Életkor
- 50 év and over
- People
- 250 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00 - 3. fázisTaking peopleA Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Where
- Berlin, Bonn, Duesseldorf, Frankfurt am Main, Goettingen, Hamburg, Heidelberg, Homburg, Ludwigshafen Am Rhein, Mainz, Marburg, Muenster, Munster, Neubrandenburg, Sulzbach, Ulm, Wuerzburg
- Életkor
- 50 év to 85 év
- People
- 975 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00 - 2/3. fázisTaking peopleA Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Where
- Bonn, Goettingen, Hanover, Leipzig, Ludwigshafen Am Rhein, Muenster, Munster, Tuebingen
- Életkor
- 60 év and over
- People
- 274 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00 - 3. fázisTaking peopleStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Where
- Berlin, Bonn, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Ludwigshafen Am Rhein, Luebeck, Muenster, Munich, Tuebingen, Ulm
- Életkor
- 50 év and over
- People
- 561 worldwide
- Run by
- AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00 - 3. fázisTaking peopleExtension Study for the Port Delivery System With Ranibizumab (Portal)
- Where
- Bonn, Cologne, Cottbus, Freiburg im Breisgau, Hamburg, Ludwigshafen Am Rhein, Muenster, Munich, Munster, Sulzbach, Tuebingen, Ulm
- Életkor
- 50 év and over
- People
- 1000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00 - 3. fázisFut, nem toborozSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Where
- Düsseldorf, Frankfurt, Neubrandenburg
- Életkor
- 50 év and over
- People
- 480 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07064759 - 2. fázisFut, nem toborozORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
- Where
- Luebeck, Tuebingen
- Életkor
- 55 év and over
- People
- 225 worldwide
- Run by
- Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00 - 3. fázisTaking peopleVitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
- Where
- Berlin, Bonn, Hamburg, Ludwigshafen Am Rhein, Muenster, Munich, Stuttgart, Sulzbach, Ulm, Würzburg
- Életkor
- 50 év to 120 év
- People
- 210 worldwide
- Run by
- King's College Hospital NHS Trust
See details and how to joinNCT04663750 · EU 2023-504751-28-00 - 2. fázisTaking peopleStudy to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Where
- Aachen, Ahaus, Baden-Baden, Bonn, Duesseldorf, Frankfurt am Main, Marburg, Wuerzburg
- Életkor
- 55 év and over
- People
- 324 worldwide
- Run by
- ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00 - No phaseTaking peopleSafety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy
- Where
- Hamburg, München, Stuttgart, Tübingen, Ulm
- Életkor
- 60 év and over
- People
- 70
- Run by
- Okuvision GmbH
See details and how to joinNCT07531927 - 2/3. fázisTaking peopleA randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
- Where
- Bonn, Frankfurt am Main, Hamburg, Hanover, Munich, Munster, Tuebingen
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Eyebiotech Limited
See details and how to join2025-524575-22-00 - No phaseCsak meghívásosReal-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality
- Where
- Göttingen
- Életkor
- 18 év and over
- People
- 22
- Run by
- University Medical Center Goettingen
See details and how to joinNCT07529041 - No phaseTaking peopleInternational Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
- Where
- Hamburg, Sulzbach, Trier, Würzburg
- Életkor
- 55 év and over
- People
- 44 worldwide
- Run by
- VisionCare, Inc.
See details and how to joinNCT07164378 - No phaseNot yet taking people in NémetországThis Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)
- Where
- Munich
- Életkor
- 18 év and over
- People
- 100
- Run by
- Johannes Schiefelbein
See details and how to joinNCT06817915 - 2. fázisNot yet taking people in NémetországLong-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
- Where
- Bonn, Freiburg im Breisgau, Hamburg, Ludwigshafen Am Rhein, Muenster, Ulm
- Életkor
- 50 év and over
- People
- 865 worldwide
- Run by
- AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00